Newsflashes | EqualOcean

All

Feb 1/ Wednesday

03:53 PM
Technology
3D Printing Company Easy 3D Made Completes Series B Financing Round

3D printing solutions provider Easy 3D Made (Chinese:易制科技) announced its completion of B-round financing, led by Hengqin Heshijia (Chinese: 横琴合世家), Horus Capital (Chinese: 华耀资本) and New World Development (Chinese: 新世界集团). The company specializes in developing advanced 3D printing products, and key features include selective laser sintering, fuse deposition molding, thin laminate manufacturing and projection light curing, providing high-quality 3D printing solutions for various industries.

Technology
03:49 PM
Technology
Bioanalytical Company InterBio Completed Pre-A Round of Financing

InterBio (Chinese: 英柏生物) is a developer of bioanalytical instrumentation software and hardware, designed for optical surface plasmon resonance technology. It announced that it successfully completed its pre-A round of financing without specifying the amount raised. This investment was led by Jintan Capital (Chinese: 金坛资本) The funds raised will be primarily used for the R&D of products, marketing and hiring of InterBio 's technical team.

Technology

Jan 31/ Tuesday

11:02 AM
Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn

Fine Vision (Chinese: 仙微视觉) announced that it had raised nearly CNY 50 million in Angel Round, which was led by DingXin Capital (Chinese: 鼎心资本) and followed by Nanjing Innovation Capital Group (Chinese: 南京创投集团). Potential Capital (Chinese: 取势资本) acted as the exclusive financial adviser. Proceeds raised in this fund will be used in the R&D and industrialization of Small Incision Lenticule Extraction (SMILE) surgery equipment. Founded in 2022, Fine Vision is an ophthalmic diseases solution provider, focusing on the development and application of SMILE on ophthalmic surgery and biological material processing. Its first commercialized product, SMILE surgery equipment is expected to break the monopoly of ZEISS's Visual Max.

Healthcare

Jan 30/ Monday

Jan 28/ Saturday

Jan 20/ Friday

Jan 19/ Thursday

Jan 18/ Wednesday

Jan 17/ Tuesday

10:36 AM
Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B

PowerSite (Chinese: 博思得) announced that it had raised a CNY 100 million Series B financing round, which was led by bioVENTURE (Chinese: 元生创投) and followed by Jiangsu Medpark (Chinese: 江苏医疗器械科技产业园) and its existing investors including SND Venture Capital (Chinese: 苏高新创投), Northern Light Venture Capital (Chinese: 北极光), and QianHui Capital (Chinese: 乾汇资本). Proceeds raised in this round will accelerate the R&D of new technology and product, the expansion of capacity and business, and the improvement of its market position. PowerSite is a medical equipment company offering overall scheme for the core components of high-end X-ray image systems.

Healthcare

LEARN MORE

共创3

In-depth

Consumer Discretionary GeerTop: China's Camping Market Growth Expected to Slow

cell culture medium

In-depth

Healthcare Chinese Company Turned the Tables on Domestic Cell Culture Media Market